WoundReference improves clinical decisions
 Choose the role that best describes you
Cressey BD, Belum VR, Scheinman P, Silvestri D, McEntee N, Livingston V, Lacouture ME, Zippin JH, et al.
Contact dermatitis. Date of publication 2017 Jan 1;volume 76(1):27-33.
1. Contact Dermatitis. 2017 Jan;76(1):27-33. doi: 10.1111/cod.12678. Epub 2016 Aug 31. Stoma care products represent a common and previously underreported source of peristomal contact dermatitis. Cressey BD(1), Belum VR(2), Scheinman P(3)(4), Silvestri D(5), McEntee N(6), Livingston V(6), Lacouture ME(2), Zippin JH(1). Author information: (1)Department of Dermatology, Weill Cornell Medical Center and New York-Presbyterian Hospital, New York, NY 10065, USA. (2)Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10022, USA. (3)Department of Dermatology, Tufts Medical Center, Boston, MA 02111, USA. (4)Department of Dermatology, Brigham and Women's Hospital, Boston, MA 02115, USA. (5)Division of Dermatology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA. (6)Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. BACKGROUND: Peristomal dermatitis is a common complication for the >700 000 patients in the United States with an ostomy. The role of stoma skin care products in peristomal dermatitis is poorly understood. OBJECTIVE: To evaluate stoma skin care products as a cause of peristomal dermatitis. METHODS: A retrospective chart review of patients with peristomal dermatitis at four academic hospitals from January 2010 to March 2014 was performed. Patient demographics, clinical information and use test and patch test results were documented. RESULTS: Eighteen patients identified as having peristomal dermatitis were tested. Twelve of these had peristomal contact dermatitis. We identified numerous stoma skin care products as triggers of irritant and/or allergic contact dermatitis. The most common stoma skin care product used and/or involved in dermatitis was Cavilon™ No Sting Barrier Film. CONCLUSIONS: Our data support a paradigm shift whereby healthcare workers treating patients with peristomal dermatitis, which is currently considered to be a reaction mainly to bodily fluids, must consider those products used to protect the skin as potential triggers for this disease. Therefore, patients with peristomal dermatitis should be tested with their stoma skin care agents to determine the need for removal or change of these products. Additionally, full ingredient labelling by manufacturers would help identify new allergens and irritants. © 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. DOI: 10.1111/cod.12678 PMCID: PMC5523875 PMID: 27576564 [Indexed for MEDLINE]
Appears in following Topics:
Case: New Technique to Seal Negative Pressure Wound Therapy on Exposed Dermis